MRNA Gross Margin
Percentage of revenue retained after cost of goods sold.
Latest Gross Margin: 35.9% (2026Q2); +19.7 pp YoY.
Across the 14 quarters from 2023Q1 to 2026Q2, Gross Margin ranged from -145.5% in 2026Q1 to 79.6% in 2025Q3.
MRNA Gross Margin
Latest: 35.9% (2026Q2)
Healthcare Comparison
1 / 3
Other MRNA Charts
More quarter-by-quarter fundamentals for Moderna, Inc.
1 / 6
Revenue
EPS
Free Cash Flow
FCF Margin
Cumulative FCF
Rule of 40